Ulotaront hydrochloride by Sumitomo Pharma America for Schizophrenia: Likelihood of Approval

Ulotaront hydrochloride is under clinical development by Sumitomo Pharma America and currently in Phase III for Schizophrenia.

Source link
#Ulotaront #hydrochloride #Sumitomo #Pharma #America #Schizophrenia #Likelihood #Approval